Effects of Lifestyle Measures, Antiobesity Agents, and Bariatric Surgery on Serological Markers of Inflammation in Obese Patients
Overweight and obesity are highly prevalent in developed countries and are also becoming more frequent in the developing world. Overweight and obese patients have elevated levels of several inflammatory markers and this inflammatory state might contribute to their increased vascular risk. We summari...
Saved in:
| Main Authors: | Konstantinos Tziomalos, Hariklia V. Dimitroula, Niki Katsiki, Christos Savopoulos, Apostolos I. Hatzitolios |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2010/364957 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plants' Metabolites as Potential Antiobesity Agents
by: Najla Gooda Sahib, et al.
Published: (2012-01-01) -
A New Era in Obesity Treatment: The Evolution of Antiobesity Medications (AOMs) Based on Clinical Trials
by: Danlu Liu, et al.
Published: (2025-06-01) -
Lipidomic markers of obesity and their dynamics after bariatric surgery
by: T. V. Saprina, et al.
Published: (2024-01-01) -
Effects of the Antiobesity Drugs Aplex and Venera on Certain Biochemical and Physiological Indices in Obese Adult Male Albino Rats
by: Suzan S. A. Elpasty, et al.
Published: (2022-01-01) -
Incretin hormone agonists as promising antiobesity drugs - review of literature
by: Aleksandra Grzegorczyk, et al.
Published: (2025-01-01)